These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28435256)

  • 1. Doxorubicin-loaded cell-derived nanovesicles: an alternative targeted approach for anti-tumor therapy.
    Goh WJ; Lee CK; Zou S; Woon EC; Czarny B; Pastorin G
    Int J Nanomedicine; 2017; 12():2759-2767. PubMed ID: 28435256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EXOPLEXs: Chimeric Drug Delivery Platform from the Fusion of Cell-Derived Nanovesicles and Liposomes.
    Goh WJ; Zou S; Lee CK; Ou YH; Wang JW; Czarny B; Pastorin G
    Biomacromolecules; 2018 Jan; 19(1):22-30. PubMed ID: 29172449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Targeting Synergistic Drug Delivery by Self-Assembled Hybrid Nanovesicles to Overcome Drug Resistance.
    Gong MQ; Wu C; He XY; Zong JY; Wu JL; Zhuo RX; Cheng SX
    Pharm Res; 2017 Jan; 34(1):148-160. PubMed ID: 27738951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin.
    Chen WL; Li F; Tang Y; Yang SD; Li JZ; Yuan ZQ; Liu Y; Zhou XF; Liu C; Zhang XN
    Int J Nanomedicine; 2017; 12():4241-4256. PubMed ID: 28652730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
    J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinspired Cell-Derived Nanovesicles versus Exosomes as Drug Delivery Systems: a Cost-Effective Alternative.
    Goh WJ; Zou S; Ong WY; Torta F; Alexandra AF; Schiffelers RM; Storm G; Wang JW; Czarny B; Pastorin G
    Sci Rep; 2017 Oct; 7(1):14322. PubMed ID: 29085024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.
    Jang SC; Kim OY; Yoon CM; Choi DS; Roh TY; Park J; Nilsson J; Lötvall J; Kim YK; Gho YS
    ACS Nano; 2013 Sep; 7(9):7698-710. PubMed ID: 24004438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors.
    van Lummel M; van Blitterswijk WJ; Vink SR; Veldman RJ; van der Valk MA; Schipper D; Dicheva BM; Eggermont AM; ten Hagen TL; Verheij M; Koning GA
    FASEB J; 2011 Jan; 25(1):280-9. PubMed ID: 20876209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted magnetic liposomes loaded with doxorubicin.
    Pradhan P; Banerjee R; Bahadur D; Koch C; Mykhaylyk O; Plank C
    Methods Mol Biol; 2010; 605():279-93. PubMed ID: 20072888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermo/pH dual-stimuli-responsive drug delivery for chemo-/photothermal therapy monitored by cell imaging.
    Shu Y; Song R; Zheng A; Huang J; Chen M; Wang J
    Talanta; 2018 May; 181():278-285. PubMed ID: 29426513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A54 Peptide Modified and Redox-Responsive Glucolipid Conjugate Micelles for Intracellular Delivery of Doxorubicin in Hepatocarcinoma Therapy.
    Liu N; Tan Y; Hu Y; Meng T; Wen L; Liu J; Cheng B; Yuan H; Huang X; Hu F
    ACS Appl Mater Interfaces; 2016 Dec; 8(48):33148-33156. PubMed ID: 27934140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembled polymer/inorganic hybrid nanovesicles for multiple drug delivery to overcome drug resistance in cancer chemotherapy.
    Gong MQ; Wu JL; Chen B; Zhuo RX; Cheng SX
    Langmuir; 2015 May; 31(18):5115-22. PubMed ID: 25927163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical characterization of pH-responsive and fusogenic self-assembled non-phospholipid vesicles for a potential multiple targeting therapy.
    Di Francesco M; Celia C; Primavera R; D'Avanzo N; Locatelli M; Fresta M; Cilurzo F; Ventura CA; Paolino D; Di Marzio L
    Int J Pharm; 2017 Aug; 528(1-2):18-32. PubMed ID: 28559215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization.
    Tinkov S; Coester C; Serba S; Geis NA; Katus HA; Winter G; Bekeredjian R
    J Control Release; 2010 Dec; 148(3):368-72. PubMed ID: 20868711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-specific delivery of a chemotherapeutic to lung cancer cells.
    Zhou X; Chang YC; Oyama T; McGuire MJ; Brown KC
    J Am Chem Soc; 2004 Dec; 126(48):15656-7. PubMed ID: 15571383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy.
    Bisht S; Maitra A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):415-25. PubMed ID: 20049807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy.
    Hua MY; Yang HW; Liu HL; Tsai RY; Pang ST; Chuang KL; Chang YS; Hwang TL; Chang YH; Chuang HC; Chuang CK
    Biomaterials; 2011 Dec; 32(34):8999-9010. PubMed ID: 21872924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine RAW264.7 cells as cellular drug delivery carriers for tumor therapy: a good idea?
    Zheng H; Li J; Luo X; Li C; Hu L; Qiu Q; Ding J; Song Y; Deng Y
    Cancer Chemother Pharmacol; 2019 Feb; 83(2):361-374. PubMed ID: 30506269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin.
    Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N
    J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.